The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
CYP2D6 allele frequency in European Caucasians, Asians, Africans and their descendants
Abstract
Over 40 cytochrome P450 (CYP) 2D6 allelic variants have been discovered thus far. The alleles may be classified on the basis of the level of activity for which they encode CYP2D6 enzymes, into functional, non-functional and reduced function groups. CYP2D6 allele frequency is known to vary amongst racial/ethnic groups. Generally, for European Caucasians and their descendants, the functional group of alleles are predominant, with a frequency of 71%. Non-functional alleles represent 26% of the variability, mainly CYP2D6*4. In Asians and their close descendants, functional alleles represent only ~ 50% of the frequency of CYP2D6 alleles. Asians and Pacific Islanders have a high frequency (median = 41%) of a reduced function allele, CYP2D6*10, contributing to the population shift to the right of metabolic rates indicating slower metabolism. Information concerning Amerindians from North (Canada), Central and South America indicate comparatively low frequencies of CYP2D6*10, perhaps a "founders" effect. The frequency of functional alleles in Africans and African Americans is also about 50%. Both Africans and African Americans have reduced function alleles representing 35% of allele variation, mainly CYP2D6*17. African Americans, however, have more than twice the median frequency of nonfunctional alleles compared with Africans (14.5% vs 6.3%). Non-functional and reduced function alleles represent about 50% of allele frequency in Black populations but a much greater variety than carried in Asians. Since alleles which encode for no or reduced functioning clearly affect metabolic activity of drugs mediated by CYP2D6, studies are needed in populations in which these alleles play a major role in order to assure optimal dosing recommendations are based on empirical pharmacogenetics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Goodman and Gilman's the Pharmacological Basis of Therapeutics
Stigelman, W. H., & Pharm, D. (1986) · Military Medicine · doi:10.1093/milmed/151.1.386 · Cited by 6,782
The History and Geography of Human Genes: Abridged paperback Edition
Cavalli-Sforza, L. L., Menozzi, P., & Piazza, A. (2018) · Princeton University Press eBooks · doi:10.2307/j.ctv301gjp · Cited by 3,175
Sachse, C., Brockmöller, J., Bauer, S., & Roots, I. (1997) · Europe PMC (PubMed Central) · Cited by 973
MOLECULAR MECHANISMS OF GENETIC POLYMORPHISMS OF DRUG METABOLISM
Meyer, U. A., & Zanger, U. M. (1997) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.37.1.269 · Cited by 549
Bertilsson, L. (1995) · Clinical Pharmacokinetics · doi:10.2165/00003088-199529030-00005 · Cited by 432
Johansson, I., Oscarson, M., Yue, Q. Y., Bertilsson, L., Sjöqvist, F., & Ingelman-Sundberg, M. (1994) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09721-4 · Cited by 430
Bertilsson, L., Lou, Y.-Q., Du, Y.-L., Liu, Y., Kuang, T.-Y., Liao, X.-M., Wang, K.-Y., Reviriego, J., Iselius, L., & Sjöqvist, F. (1992) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1992.38 · Cited by 399
Nomenclature for human CYP2D6 alleles
Daly, A. K., Brockmoller, J., Broly, F., Eichelbaum, M., Evans, W. E., Gonzalez, F. J., Huang, J. D., Idle, J. R., Ingelman-Sundberg, M., Ishizaki, T., et al. (1996) · Pharmacogenetics · doi:10.1097/00008571-199606000-00001 · Cited by 396
Aklillu, E., Persson, I., Bertilsson, L., Johansson, I., Rodrigues, F., & Ingelman-Sundberg, M. (1996) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)20152-5 · Cited by 392
Marez, D., Legrand, M., Sabbagh, N., Lo Guidice, J.-M., Spire, C., Lafitte, J.-J., Meyer, U. A., & Broly, F. (1997) · Pharmacogenetics · doi:10.1097/00008571-199706000-00004 · Cited by 380
Griese, E.-U., Zanger, U. M., Brudermanns, U., Gaedigk, A., Mikus, G., M??rike, K., St??ven, T., & Eichelbaum, M. (1998) · Pharmacogenetics · doi:10.1097/00008571-199802000-00003 · Cited by 283
Comprehensive analysis of the genetic factors determining expression and function of hepatic CYP2D6
Zanger, U. M., Fischer, J., Raimundo, S., Stüven, T., Evert, B. O., Schwab, M., & Eichelbaum, M. (2001) · Pharmacogenetics · doi:10.1097/00008571-200110000-00004 · Cited by 266
Molecular basis for rational megaprescribing in ultrarapid hydroxylators of debrisoquine
Bertilsson, L., Dahl, M.-L., Sjöqvist, F., Åberg-Wistedt, A., Humble, M., Johansson, I., Lundqvist, E., & Ingelman-Sundberg, M. (1993) · The Lancet · doi:10.1016/0140-6736(93)92546-6 · Cited by 223
BROLY, F., GAEDIGK, A., HEIM, M., EICHELBAUM, M., MORIKE, K., & MEYER, U. A. (1991) · DNA and Cell Biology · doi:10.1089/dna.1991.10.545 · Cited by 219
Frequent occurrence of CYP2D6 gene duplication in Saudi Arabians
McLellan, R. A., Oscarson, M., Seidega??rd, J., Price Evans, D. A., & Ingelman-Sundberg, M. (1997) · Pharmacogenetics · doi:10.1097/00008571-199706000-00003 · Cited by 204
Bock, K. W., Schrenk, D., Forster, A., Griese, E.-U., M??rike, K., Brockmeier, D., & Eichelbaum, M. (1994) · Pharmacogenetics · doi:10.1097/00008571-199408000-00005 · Cited by 199
Raimundo, S., Fischer, J., Eichelbaum, M., Griese, E.-U., Schwab, M., & Zanger, U. M. (2000) · Pharmacogenetics · doi:10.1097/00008571-200010000-00001 · Cited by 189
Gaedigk, A., Gotschall, R. R., Forbes, N. S., Simon, S. D., Kearns, G. L., & Leeder, J. S. (1999) · Pharmacogenetics and Genomics · doi:10.1097/01213011-199912000-00002 · Cited by 181
Low frequency of defective alleles of cytochrome P450 enzymes 2C19 and 2D6 in the Turkish population
AYNACIOGLU, A., Sachse, C., Bozkurt, A., et al. (1999) · Clinical Pharmacology & Therapeutics · doi:10.1053/cp.1999.v66.100072001 · Cited by 151
A Combination of Mutations in the CYP2D6*17(CYP2D6Z) Allele Causes Alterations in Enzyme Function
Oscarson, M., Hidestrand, M., Johansson, I., & Ingelman‐Sundberg, M. (1997) · Molecular Pharmacology · doi:10.1124/mol.52.6.1034 · Cited by 141
Interethnic variation of drug metabolism
KALOW, W. (1991) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(91)90516-u · Cited by 127
TATEISHI, T., Chida, M., Ariyoshi, N., et al. (1999) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(99)70077-9 · Cited by 117
CYP2D6 phenotype ??? genotype relationships in African-Americans and Caucasians in Los Angeles
Leathart, J. B. S., London, S. J., Steward, A., et al. (1998) · Pharmacogenetics · doi:10.1097/00008571-199812000-00010 · Cited by 114
Evans, W. E., Relling, M. V., Rahman, A., McLeod, H. L., Scott, E. P., & Lin, J. S. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116441 · Cited by 109
Løvlie, R., Daly, A. K., Matre, G. E., Molven, A., & Steen, V. M. (2001) · Pharmacogenetics · doi:10.1097/00008571-200102000-00006 · Cited by 101
Dandara, C., Masimirembwa, C. M., Magimba, A., Sayi, J., Kaaya, S., Sommers, D. K., Snyman, J. R., & Hasler, J. A. (2001) · European Journal of Clinical Pharmacology · doi:10.1007/s002280100282 · Cited by 101
Relling, M. V., Cherrie, J. W., Schell, M. J., Petros, W. P., Meyer, W. H., & Evans, W. E. (1991) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1991.141 · Cited by 100
Bernal, M. L., Sinués, B., Johansson, I., McLellan, R. A., Wennerholm, A., Dahl, M., Ingelman‐Sundberg, M., & Bertilsson, L. (1999) · Pharmacogenetics and Genomics · doi:10.1097/00008571-199910000-00013 · Cited by 97
Comparison of three CYP2D6 probe substrates and genotype in Ghanaians, Chinese and Caucasians
Droll, K. P., Bruce-Mensah, K., Otton, S. V., Gaedigk, A., Sellers, E. M., & Tyndale, R. F. (1998) · Pharmacogenetics · doi:10.1097/00008571-199808000-00006 · Cited by 97
Dahl, M., Yue, Q., Roh, H., et al. (1995) · Pharmacogenetics · doi:10.1097/00008571-199506000-00004 · Cited by 95
Ethnicity and psychopharmacology
Lin, K., Poland, R. E., & Lesser, I. M. (1986) · Culture Medicine and Psychiatry · doi:10.1007/bf00156581 · Cited by 87
Wennerholm, A., Johansson, I., Hidestrand, M., Bertilsson, L., Gustafsson, L. L., & Ingelman‐Sundberg, M. (2001) · Pharmacogenetics · doi:10.1097/00008571-200107000-00005 · Cited by 78
CYP2D6 polymorphism in a Mexican American population
Mendoza, R., Wan, Y. Y., Poland, R. E., Smith, M. W., Zheng, Y., Berman, N., & Lin, K. (2001) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(01)00793-7 · Cited by 77
Wennerholm, A., Johansson, I., Massele, A. Y., et al. (1999) · PubMed · Cited by 75
Dalén, P., Dahl, M., Eichelbaum, M., Bertilsson, L., & Wilkinson, G. R. (1999) · Pharmacogenetics and Genomics · doi:10.1097/01213011-199912000-00004 · Cited by 54
Lf, J., Eichelbaum, M., Griese, E.-U., Inaba, T., & Td, A. (1999) · PubMed · Cited by 53
Bradford, L. D., Gaedigk, A., & Js, L. (1998) · PubMed · Cited by 41
Self-citationPharmacokinetic and other related factors affecting psychotropic responses in Asians.
Lin, K., Poland, R. E., Smith, M. W., Strickland, T. L., & Mendoza, R. (1991) · PubMed · Cited by 39
Cited by
Ingelman-Sundberg, M. (2005) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500285 · Cited by 1,108
(2007) · PubMed · Cited by 953
Jin, Y., Desta, Z., Stearns, V., Ward, B., Ho, H., Lee, K.-H., Skaar, T., Storniolo, A. M., Li, L., Araba, A., et al. (2005) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dji005 · Cited by 951
Polymorphism of Human Cytochrome P450 2D6 and Its Clinical Significance: Part I
Zhou, S.-F. (2009) · Clinical Pharmacokinetics · doi:10.2165/11318030-000000000-00000 · Cited by 756
Kirchheiner, J., Nickchen, K., Bauer, M., Wong, M.-L., Licinio, J., Roots, I., & Brockmöller, J. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001494 · Cited by 724
Metadata
- Authors
- Bradford, L. D.
- Venue
- Pharmacogenomics
- Publisher
- Informa UK Limited
- Published
- 2002-03
- Volume
- 3
- Issue
- 2
- Pages
- 229-243
- ISSN
- 1462-2416 (ISSN-L)
- 1744-8042
- OpenAlex
- W2098867544
- Cited by
- 773
- References
- 38
- FWCI
- 14.23
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.